Search filters

List of works by Federica Maione

A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent

scientific article published on 01 May 2018

AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.

scientific article

Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling

scientific article published on 2 September 2016

Class 3 semaphorins in cardiovascular development.

scientific article published on 20 July 2016

Class 3 semaphorins: physiological vascular normalizing agents for anti‐cancer therapy ⬇️

scientific article published on February 1, 2013

Erratum: Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling.

scientific article published on 11 November 2016

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.

scientific article published on 29 November 2017

Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane

scientific article published on 22 June 2010

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity

scientific article published on 5 May 2016

Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.

scientific article published on 30 September 2017

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

scientific article published on 17 October 2016

Osteopontin binds ICOSL promoting tumor metastasis

scientific article published on 26 October 2020

Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor

scientific article published on 28 June 2014

Proteomics-based metabolic modeling reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability

scientific article

Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program.

scientific article published on 20 July 2017

Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models

scientific article published on 05 October 2009

Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice

scientific article published on 9 April 2012

Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages.

scientific article

Semaphorins and tumor angiogenesis.

scientific article published on 06 March 2009

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

scientific article published on 27 December 2011

Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategy

scientific article published on 10 May 2018

The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination

scientific article

Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models

scientific article published on 01 August 2018

Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.

scientific article published in January 2015

Tumour growth inhibition and anti‐metastatic activity of a mutated furin‐resistant Semaphorin 3E isoform ⬇️

scientific article published on January 13, 2012

α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.

scientific article published on 9 July 2018

Paulina is supported by:

About Paulina

Help